Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
45
DNLI Quote, Financials, Valuation and Earnings
Last price:
$17.01
Seasonality move
:
-13.05%
Day range:
$16.72 - $17.05
52-week range:
$10.57 - $24.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.62x
P/B ratio:
2.86x
Volume:
505K
Avg. volume:
1.6M
1-year change:
-18.79%
Market cap:
$2.7B
Revenue:
--
EPS (TTM):
-$2.91
Earnings Data
Next earnings date for DNLI
Mar 02
2026
Most recent earnings per share
-$0.74
Beat by $0.02
(Nov 6/2025)
Consensus Estimate
-$0.76
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DNLI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/02/2026 | Q4 | $2.9M | -- | -- | -$0.76 | -- |
| 11/06/2025 | Q3 | $1M | -- | -$0.74 | -$0.76 | $0.02 |
| 08/11/2025 | Q2 | $5.6M | -- | -$0.72 | -$0.74 | $0.01 |
| 05/06/2025 | Q1 | $3M | -- | -$0.78 | -$0.70 | -$0.07 |
| 02/27/2025 | Q4 | $12.8M | -- | -$0.67 | -$0.85 | $0.17 |
| 11/06/2024 | Q3 | $8.4M | -- | -$0.63 | -$0.63 | -$0.00 |
| 08/01/2024 | Q2 | $10.8M | -- | -$0.59 | -$0.69 | $0.11 |
| 05/07/2024 | Q1 | $13M | -- | -$0.68 | -$0.66 | -$0.02 |
| 02/27/2024 | Q4 | $7.8M | -- | -$0.86 | -$0.78 | -$0.08 |
| 11/07/2023 | Q3 | $11.2M | $1.3M | -$0.72 | -$0.79 | $0.07 |
| 08/08/2023 | Q2 | -- | $294.1M | $1.30 | -- | -- |
| 05/08/2023 | Q1 | -- | $35.1M | -$0.80 | -- | -- |
| 02/27/2023 | Q4 | -- | $10.3M | -$0.74 | -- | -- |
| 11/03/2022 | Q3 | -- | $3.6M | -$0.84 | -- | -- |
| 08/08/2022 | Q2 | -- | $52.5M | -$0.48 | -- | -- |
| 05/05/2022 | Q1 | -- | $42.1M | -$0.53 | -- | -- |
| 02/28/2022 | Q4 | -- | $12.5M | -$0.62 | -- | -- |
| 11/04/2021 | Q3 | -- | $5.3M | -$0.69 | -- | -- |
| 08/04/2021 | Q2 | -- | $22.9M | -$0.50 | -- | -- |
| 05/05/2021 | Q1 | -- | $7.9M | -$0.58 | -- | -- |
| 02/25/2021 | Q4 | -- | $316.8M | $1.91 | -- | -- |
| 11/05/2020 | Q3 | -- | $9.4M | -$0.54 | -- | -- |
| 08/07/2020 | Q2 | -- | $5.8M | -$0.56 | -- | -- |
| 05/07/2020 | Q1 | -- | $3.6M | -$0.55 | -- | -- |
| 12/31/2019 | Q4 | -- | $4.7M | -$0.56 | -- | -- |
| 09/30/2019 | Q3 | -- | $13.6M | -$0.48 | -- | -- |
| 06/30/2019 | Q2 | -- | $4.2M | -$0.61 | -- | -- |
| 03/31/2019 | Q1 | -- | $4.2M | -$0.41 | -- | -- |
| 12/31/2018 | Q4 | -- | $125.7M | $0.79 | -- | -- |
| 09/30/2018 | Q3 | -- | $1.2M | -$0.38 | -- | -- |
| 06/30/2018 | Q2 | -- | $1.6M | -$0.59 | -- | -- |
| 03/31/2018 | Q1 | -- | $641K | -$0.26 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.74 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$0.25 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | $1.81 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$0.21 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.34 | -- | -- |
Denali Therapeutics, Inc. Earnings Questions
-
How Much did Denali Therapeutics, Inc. Generate in Revenue Last Quarter?
Denali Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Denali Therapeutics, Inc. Beat Earnings Last Quarter?
Denali Therapeutics, Inc. announced earnings per share of -$0.74 which represents a beat of analyst forecast a -$0.76 per share.
-
Is Denali Therapeutics, Inc. Profitable?
Denali Therapeutics, Inc. reported -$2.9M that represents -$0.02 per share over the last quarter.
-
What is the Analyst Consensus for Denali Therapeutics, Inc. EPS Next Year?
Denali Therapeutics, Inc.'s earnings are forecast to decrease from -$2.57 per share to -$2.75 per share next year representing a decrease of -17.23%.
-
When is Denali Therapeutics, Inc.'s Earnings Date?
Denali Therapeutics, Inc.'s next earnings date is March 2, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
